Equities analysts expect Mandiant Inc (NASDAQ:MNDT) to post $131.73 million in sales for the current quarter, Zacks reports. Three analysts have issued estimates for Mandiant’s earnings, with the lowest sales estimate coming in at $131.10 million and the highest estimate coming in at $133.00 million. Mandiant posted sales of $247.50 million during the same quarter last year, which would indicate a negative year over year growth rate of 46.8%. The company is expected to announce its next quarterly earnings results on Tuesday, February 1st.
According to Zacks, analysts expect that Mandiant will report full-year sales of $482.31 million for the current year, with estimates ranging from $481.66 million to $483.60 million. For the next fiscal year, analysts anticipate that the firm will post sales of $570.54 million, with estimates ranging from $554.50 million to $586.67 million. Zacks’ sales averages are a mean average based on a survey of sell-side research analysts that follow Mandiant.
Mandiant (NASDAQ:MNDT) last posted its quarterly earnings results on Thursday, November 4th. The company reported $0.06 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of ($0.33) by $0.39. Mandiant had a negative return on equity of 9.97% and a negative net margin of 30.46%. The firm had revenue of $121.97 million during the quarter, compared to the consensus estimate of $120.78 million. During the same quarter in the previous year, the business earned ($0.06) earnings per share. The firm’s quarterly revenue was up 21.9% compared to the same quarter last year.
Several equities analysts have recently commented on MNDT shares. Barclays lowered their target price on Mandiant from $20.00 to $19.00 and set an “underweight” rating for the company in a report on Wednesday, October 13th. Colliers Securities restated a “buy” rating on shares of Mandiant in a research report on Friday, November 5th. Zacks Investment Research upgraded Mandiant from a “sell” rating to a “hold” rating in a research report on Wednesday, December 8th. Morgan Stanley started coverage on Mandiant in a research report on Thursday, October 7th. They set an “equal weight” rating and a $19.00 price objective for the company. Finally, The Goldman Sachs Group started coverage on Mandiant in a report on Tuesday, October 19th. They issued a “neutral” rating for the company. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and one has assigned a buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $19.00.
NASDAQ:MNDT opened at $16.71 on Tuesday. The company has a debt-to-equity ratio of 0.93, a quick ratio of 1.28 and a current ratio of 1.28. Mandiant has a one year low of $15.72 and a one year high of $25.53. The stock has a 50-day simple moving average of $17.55. The firm has a market capitalization of $4.01 billion, a PE ratio of -16.54 and a beta of 0.94.
In related news, COO John P. Watters bought 10,000 shares of Mandiant stock in a transaction that occurred on Tuesday, November 23rd. The stock was acquired at an average price of $16.55 per share, for a total transaction of $165,500.00. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Ronald E. F. Codd sold 40,000 shares of the stock in a transaction dated Monday, November 8th. The shares were sold at an average price of $18.05, for a total transaction of $722,000.00. The disclosure for this sale can be found here. 2.10% of the stock is owned by corporate insiders.
Several hedge funds and other institutional investors have recently added to or reduced their stakes in MNDT. Graypoint LLC bought a new position in Mandiant during the third quarter worth about $184,000. Captrust Financial Advisors bought a new position in Mandiant during the third quarter worth about $248,000. Tudor Investment Corp Et Al bought a new position in Mandiant during the third quarter worth about $1,163,000. Finally, Marshall Wace LLP bought a new position in Mandiant during the third quarter worth about $17,713,000. Institutional investors and hedge funds own 84.13% of the company’s stock.
Mandiant, Inc operates as an intelligence-led security company. The firm engages in intelligence-based cybersecurity solutions that allow organizations to prepare for, prevent, respond to and remediate cyber attacks. It operates through the following geographical segments: United States; EMEA; APAC; and Other.
Featured Story: Why Invest in Dividend Kings
For more information about research offerings from Zacks Investment Research, visit Zacks.com
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to [email protected]
Before you consider Mandiant, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Mandiant wasn’t on the list.
While Mandiant currently has a “Hold” rating among analysts, top-rated analysts believe these five stocks are better buys.